BLOSSOM JOSE: Open Payments
NPI 1750983318 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 19 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $626 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $133 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| SOBI, INC | 3 | $89 |
| Syndax Pharmaceuticals, Inc. | 2 | $64 |
| Incyte Corporation | 2 | $50 |
| ABBVIE INC. | 1 | $33 |
| PharmaEssentia USA Corporation | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Products named: OJJAARA, CALQUENCE, Vonjo, JAKAFI, EPKINLY, Gamifant, BESREMI, SCEMBLIX.
Industry payments across TX — which companies pay providers there.
